P-glycoprotein polymorphism and levothyroxine bioavailability in hypothyroid patients.

Öztas, Ezgi; Parejo Garcia-Saavedra, Alejandro; Yanar, Fatih; Özçinar, Beyza; Aksakal, Nihat; Purisa, Sevim; Özhan, Gül

Öztas, Ezgi; Parejo Garcia-Saavedra, Alejandro; Yanar, Fatih; Özçinar, Beyza; Aksakal, Nihat; Purisa, Sevim; Özhan, Gül.

Affiliation

Öztas E; Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 34116 Beyazit, Istanbul, Turkey.
Parejo Garcia-Saavedra A; Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 34116 Beyazit, Istanbul, Turkey.
Yanar F; Istanbul University, Faculty of Medicine, Department of General Surgery, 34093 Fatih, Istanbul, Turkey.
Özçinar B; Istanbul University, Faculty of Medicine, Department of General Surgery, 34093 Fatih, Istanbul, Turkey.
Aksakal N; Istanbul University, Faculty of Medicine, Department of General Surgery, 34093 Fatih, Istanbul, Turkey.
Purisa S; Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Technology, 34116 Beyazit, Istanbul, Turkey.
Özhan G; Istanbul University, Faculty of Pharmacy, Department of Pharmaceutical Toxicology, 34116 Beyazit, Istanbul, Turkey.

Saudi Pharm J ; 26(2): 274-278, 2018 Feb.

Article de En | MEDLINE | ID: mdl-30166928

Mots clés

Hypothyroidism; Levothyroxine; MDR1 polymorphisms; P-glycoprotein

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Saudi Pharm J Année: 2018 Type de document: Article Pays d'affiliation: Turquie

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google